WahanaRiau.com - Aim immunotech

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Aim immunotech

Index

Globenewswire

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

Kamis, 19 Maret 2026 - 04:13:18 Wib

Globenewswire

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Jumat, 26 September 2025 - 00:14:53 Wib

Aim immunotech

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Terpopuler

Juungar Banner: Building a "Reserve of Seed Crabs" on Saline-Alkali Flats
Dibaca: 103 Kali

Chubb Life Announces Australian Open 2027 Tickets Giveaway Social Campaign & Live Viewing Party
Dibaca: 105 Kali

AOX recognised as APAC’s Top Collagen-Renewing Water Dispensers in 2026 by Healthcare Business Review
Dibaca: 112 Kali

Sun Group Facilities in Ha Long Connect Bay Cruises With Shore Activities Ahead of November
Dibaca: 106 Kali

Regent Hong Kong Announces "Symphony of Hanwoo: Chef David Lee x Chef Amine Errkhis 4-Hands Culinary Journey" at The Steak House
Dibaca: 131 Kali

Terkini

CPA Australia Congress 2026 in Hong Kong brings think tanks to shape the future

Alibaba Cloud Launches First Public Cloud Region in the Netherlands

Vision Engineering Brings 4K Inspection to Malaysia

BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

Huawei Wireless Unveils Innovation Breakthroughs to Pioneer New Communications Networks

Aim immunotech

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Terpopuler

Juungar Banner: Building a "Reserve of Seed Crabs" on Saline-Alkali Flats Dibaca: 103 Kali

Chubb Life Announces Australian Open 2027 Tickets Giveaway Social Campaign & Live Viewing Party Dibaca: 105 Kali

AOX recognised as APAC’s Top Collagen-Renewing Water Dispensers in 2026 by Healthcare Business Review Dibaca: 112 Kali

Sun Group Facilities in Ha Long Connect Bay Cruises With Shore Activities Ahead of November Dibaca: 106 Kali

Regent Hong Kong Announces "Symphony of Hanwoo: Chef David Lee x Chef Amine Errkhis 4-Hands Culinary Journey" at The Steak House Dibaca: 131 Kali

Terkini

CPA Australia Congress 2026 in Hong Kong brings think tanks to shape the future

Alibaba Cloud Launches First Public Cloud Region in the Netherlands

Vision Engineering Brings 4K Inspection to Malaysia

BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

Huawei Wireless Unveils Innovation Breakthroughs to Pioneer New Communications Networks

Juungar Banner: Building a "Reserve of Seed Crabs" on Saline-Alkali Flats
Dibaca: 103 Kali

Chubb Life Announces Australian Open 2027 Tickets Giveaway Social Campaign & Live Viewing Party
Dibaca: 105 Kali

AOX recognised as APAC’s Top Collagen-Renewing Water Dispensers in 2026 by Healthcare Business Review
Dibaca: 112 Kali

Sun Group Facilities in Ha Long Connect Bay Cruises With Shore Activities Ahead of November
Dibaca: 106 Kali

Regent Hong Kong Announces "Symphony of Hanwoo: Chef David Lee x Chef Amine Errkhis 4-Hands Culinary Journey" at The Steak House
Dibaca: 131 Kali